Therapeutic Solutions International (Therapeutic Solutions International) Days Sales Outstanding : 77.94 (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Therapeutic Solutions International Days Sales Outstanding?

Therapeutic Solutions International's average Accounts Receivable for the three months ended in Dec. 2023 was $0.02 Mil. Therapeutic Solutions International's Revenue for the three months ended in Dec. 2023 was $0.02 Mil. Hence, Therapeutic Solutions International's Days Sales Outstanding for the three months ended in Dec. 2023 was 77.94.

The historical rank and industry rank for Therapeutic Solutions International's Days Sales Outstanding or its related term are showing as below:

TSOI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 14.48 Med: 40.56 Max: 365
Current: 75.21

During the past 13 years, Therapeutic Solutions International's highest Days Sales Outstanding was 365.00. The lowest was 14.48. And the median was 40.56.

TSOI's Days Sales Outstanding is ranked worse than
52.57% of 894 companies
in the Biotechnology industry
Industry Median: 72.38 vs TSOI: 75.21

Therapeutic Solutions International's Days Sales Outstanding declined from Dec. 2022 (339.65) to Dec. 2023 (77.94).

Therapeutic Solutions International Days Sales Outstanding Historical Data

The historical data trend for Therapeutic Solutions International's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Therapeutic Solutions International Days Sales Outstanding Chart

Therapeutic Solutions International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

40.56

14.48

23.75

37.03

81.11

Therapeutic Solutions International Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															339.65	85.30	63.17	70.19	77.94

Competitive Comparison of Therapeutic Solutions International's Days Sales Outstanding

For the Biotechnology subindustry, Therapeutic Solutions International's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Therapeutic Solutions International's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Therapeutic Solutions International's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Therapeutic Solutions International's Days Sales Outstanding falls into.

Therapeutic Solutions International Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Therapeutic Solutions International's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.025	+	0.019)	/	2 )	/	0.099	*	365
=	0.022					/	0.099	*	365
=	81.11

Therapeutic Solutions International's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.022	+	0.019)	/	2 )	/	0.024	*	365 / 4
=	0.0205					/	0.024	*	365 / 4
=	77.94

Therapeutic Solutions International (OTCPK:TSOI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Therapeutic Solutions International Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Therapeutic Solutions International's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Therapeutic Solutions International (Therapeutic Solutions International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Therapeutic Solutions International Inc (OTCPK:TSOI) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

701 Wild Rose Lane, Elk City, ID, USA, 83525

Website

https://www.therapeuticsolutionsint.com

Therapeutic Solutions International Inc focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division which produces nutraceuticals. Its current product, QuadraMune, is a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone. Cellular Division obtained exclusive rights to a patented adult stem cell for the development of therapeutics in the area of chronic traumatic encephalopathy (CTE) and traumatic brain injury (TBI) and Lung Pathology (LP).

Executives

Thomas Ichim	director	211 E. OSBORN RD, PHOENIX AZ 85012
Gerry B Berg	officer: CFO	1658 AVENIDA LA POSTA, ENCINITAS CA 92024
Timothy G Dixon	director, officer: Chairman, President, CEO	4093 OCEANSIDE BLVD., SUITE B, OCEANSIDE CA 92056
Barry Glassman	officer: VP, Training & Education	2051 ELBOW LANE, ALLENTOWN PA 18103
James P Boyd	director, 10 percent owner	PO BOX 2145, RANCHO SANTA FE CA 92067